# Relmada Therapeutics, Inc.: Form SC 13D, filed Oct 22, 2015

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: SC 13D
- Filed: 2015-10-22
- Accepted by EDGAR: Oct 21, 2015, 17:43 ET
- Period: not reported
- Accession: 0001144204-15-060273
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000114420415060273/v422530_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000114420415060273/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000114420415060273/v422530_sc13d.htm

Filed Oct 22, 2015.
Source: SEC EDGAR, the filing index for accession 0001144204-15-060273. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
